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Vibrio cholerae, the gram-negative organism
that causes cholera, is well defined on the basis of
biochemical tests and DNA homology studies (1),
but the serogroups of the species differ in their
pathogenic potential. Of the 193 recognized “O”
serogroups of V. cholerae (2), only O1 and O139
cause epidemic and pandemic cholera.
V. cholerae O139 was first identified in
September 1992 in southern India (3) and rapidly
spread to all cholera-endemic areas in India (4)
and neighboring countries (5). In February 1994,
a new clone of V. cholerae O1 El Tor biotype (6)
replaced the O139 serogroup as the dominant
serogroup causing cholera in Calcutta (7). After a
33-month quiescent period, a new clone of
V. cholerae O139 (8,9) appeared in August 1996 in
Calcutta (10) and was the dominant serogroup
until September 1997. This new clone has also
spread to other parts of India (11).
The National Institute of Cholera and Enteric
Diseases, Calcutta, conducts continuous surveil-
lance for cholera in Calcutta in particular, and in
India in general. During September-October
1998, we observed an increase in the incidence of
O139 cholera, prompting study of these O139
strains. We report the findings of surveillance
performed from September 1992 to December
1998 in India, which enabled us to track and
catalog changes in the O139 strains since its
identification.
The Study
Hospital Surveillance and Bacteriology
Stool specimens were obtained from patients
admitted to the Infectious Diseases Hospital,
Calcutta, the only hospital that admits cholera
patients from the city and its suburbs. Since 1995,
on two randomly selected days per week, every
fifth patient has been enrolled from all patients
with diarrhea or dysentery, with or without other
complaints, visiting the emergency department of
the Infectious Diseases Hospital, Calcutta.
Before 1995, only patients with diarrhea
admitted to the Infectious Diseases Hospital,
Calcutta, from Monday to Friday between 9 a.m.
and 1 p.m. were enrolled. Methods of collection,
transport, and bacteriologic examination of stool
samples and identification and serotyping of
V. cholerae have been described (7). The National
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Table 1. Oligonucleotide primer sequences used in
polymerase chain reaction assays of Vibrio cholerae O139
Amplicon
     size
Gene Primer  sequence  (5'-3')         (bp) Ref.
ctxA CTCAGACGGGATTTGTTAGGCACG   301 14
TCTATCTCTGTAGCCCCTATTACG
tcpA GAAGAAGTTTGTAAAAGAAGAACAC   471 14
(El Tor) GAAGGACCTTCTTTCACGTTG
tcpA CACGATAAGAAAACCGGTCAAGAG   617 16
(clas- ACCAAATGCAACGCCGAATGGAG
 sical)
ace GCTTATGATGGACACCCTTTA   282 15,a
TTTAACGCTCGCAGGGC
zot GGGCGAGAAAGGACGC   834   a
CCTTGTAGCGGTAGCTCG
aReferred to in this study.
Institute of Cholera and Enteric Diseases,
Calcutta, is India’s national reference laboratory
for cholera, and strains from throughout the
country are sent here for confirmation and phage
typing. Strains received are characterized by an
array of tests (4). In this study, representative
strains of V. cholerae O139 isolated from
hospitalized patients in Calcutta from 1992 to
1998 and 15 V. cholerae O139 strains from other
parts of India (eastern, central, northern, and
southern India) isolated in 1998 were randomly
selected for molecular characterization.
Antimicrobial Susceptibility
The  V. cholerae O139 strains were examined
for resistance to ampicillin (10 ￿g), chlorampheni-
col (30 ￿g), cotrimoxazole (25 ￿g), ciprofloxacin (5
￿g), furazolidone (100 ￿g), gentamycin (10 ￿g),
neomycin (30 ￿g), nalidixic acid (30 ￿g),
norfloxacin (10 ￿g), streptomycin (10 ￿g), and
tetracycline (30 ￿g) by using antibiotic-
impregnated commercial disks (Hi Media,
Mumbai, India). Characterization of the strains
as susceptible or resistant was based on the size
of inhibition zones around each disk, according to
the manufacturer’s instructions, which followed
World Health Organization recommendations
(12). Strains showing an intermediate zone of
inhibition were interpreted as resistant on the
basis of previous minimum inhibitory concentra-
tion studies conducted with V. cholerae (13).
Polymerase Chain Reaction (PCR) Assay
PCR assays (both multiple and single) were
used to screen the O139 strains for five important
virulence genes. The first PCR assay used three
pairs of oligonucleotide primers for virulence
genes  ctxA (301 bp), tcpA (classical; 617 bp), and
tcpA (El Tor; 471 bp), and the second and third
PCR assays used primer pairs for the virulence
genes  zot and ace, respectively (Table 1) (15). The
composition of the reaction mix and cycling
conditions for amplification have been described (16).
Amplification was done by using an
automated thermal cycler (Biometra Gottingen,
Germany).  V. cholerae strain VC20 (El Tor,
Ogawa), 569B (classical, Inaba) and Escherichia
coli DH5-α   strains were used as positive and
negative controls. Amplified products were
electrophoresed in a 2% agarose gel (SRL,
Bombay, India) in 1x TAE buffer along with
standard molecular weight markers (MWM),
stained with ethidium bromide (Sigma), and
recorded with a video documentation system
(Pharmacia Biotech, San Francisco, CA).
Pulsed-Field Gel Electrophoresis (PFGE)
Genomic DNA of various strains of V. cholerae
was prepared in agarose plugs (17). For complete
digestion of the DNA, 50U of NotI enzyme was
used. PFGE of inserts was done by the contour-
clamped homogeneous electric field method on a
CHEF-mapper (Bio-Rad) with 0.5x TBE Buffer
[44.5 mM Tris, 44.5 mM boric acid, 1 mM EDTA
(pH 8.0)] for 40.24 hours. A DNA size standard
(λ -ladder; Bio-Rad) was used as molecular weight
standard. A model 1,000 minichiller (Bio-Rad)
was used to maintain the temperature of buffer at
14°C. Run conditions were generated by the auto-
algorithm mode of a CHEF Mapper PFGE system
with a size range of 20-300 kb. Gels were stained
in distilled water containing 1.0 ￿g ethidium
bromide per ml for 30 minutes, rinsed several
times, and photographed. After electrophoresis,
ethidium bromide staining and photography,
transfer of DNA from gel to Hybond N+ membrane
(Amersham International PLC, Buckinghamshire,
England) and Southern blot hybridization with an
O139-specific probe were done as described (17).
The DNA adjacent to Tn5lac insertion in
MO10 (an O139 strain from the Madras outbreak)
rendered the strain O139 negative in agglutin-
ability with O139-specific antiserum. The O139
probe used in this study was prepared as
described earlier (18).
Restriction Fragment Length Polymorphism
(RFLP) of ctxA Gene and O139 Specific Gene
A  ctxA probe consisting of a 540-bp XbaI-ClaI
fragment of ctxA cloned in pKTN901 with EcoRI141 Vol. 6, No. 2, March–April 2000 Emerging Infectious Diseases
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Figure 1. Monthly isolation profile of the Vibrio
cholerae O1 and O139 serogroups from patients
hospitalized with acute secretory diarrhea at the
Infectious Diseases Hospital, Calcutta, India, from
March 1992 to December 1998. Arrows denote the
month in which changes in V. cholerae strains were
noted: A, appearance of V. cholerae O139 in Calcutta
in November 1992; B, displacement of V. cholerae O1
by  V. cholerae O139 in January 1993; C, reappearance
of V. cholerae O1; D, domination of V. cholerae O1 over
V. cholerae O139; E, isolation of nontoxigenic
V. cholerae O139 in April 1995; F, appearance for the
first time of cotrimoxazole-susceptible strains of
V. cholerae O139; G, appearance of cotrimoxazole-
susceptible and neomycin-resistant strains of
V. cholerae O139; H, domination of V. cholerae O139
over V. cholerae O1; I, replacement of V. cholerae O139
by  V. cholerae O1 as the major cholera causing
serogroup; J, appearance of cotrimoxazole- and
streptomycin-susceptible strains of V. cholerae O139.
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Figure 2. Monthly isolation profile of the percentage of
V. cholerae O1 and O139 serogroups from patients
hospitalized with acute secretory diarrhea at the
Infectious Diseases Hospital, Calcutta, India, from
March 1992 to December 1998.
linkers was used (19). A modification of the method
of Murray and Thompson (20) was used for DNA
extraction for ctx RFLP (16). The transfer of DNA
from gel to Hybond N+ membrane (Amersham)
and hybridization with probes was done (16) with
the ECL Nucleic Acid Detection System
(Amersham). The membranes were then washed
and exposed to Kodak Biomax film (Eastman
Kodak Co., Rochester, NY) and developed according
to manufacturer’s instructions.
Results
The O139 serogroup dominated as the major
cholera-causing serogroup in 1993 and from
September 1996 to September 1997, while the O1
serogroup dominated during the remaining part
of the study period (Figures 1, 2). The rate of
isolation of O139 serogroup was lower in 1998
than in any other year since 1992, the year it was
identified (Table 2). The seasonality in incidence
of the O139 serogroup showed an interesting
trend: apart from 1993 and 1994, more O139
cholera cases were recorded during the latter half
of the year, coinciding with the second peak of
cholera cases (Figures 1, 2). However, the peak
incidence of cholera caused by the O1 serogroup
was generally observed during June-July, except
for 1993 and 1997, when the O1 peak occurred
during October and September, respectively
(Figures 1, 2). The O139 strains were the
dominant cholera-causing serogroup during
these years (Table 2; Figures 1, 2).
The antibiotic resistance patterns of ran-
domly selected O139 strains isolated from
Calcutta during 1992-1998 (Figure 3) showed
dramatic changes in resistance to cotrimoxazole,
with all the 1992, 1993, and 1994 O139 strains
being resistant, while most of the strains isolated
during 1997 and 1998 were sensitive. Likewise,
resistance to neomycin and streptomycin also
increased until 1996, then declined. O139 strains
isolated throughout the study were resistant to
furazolidone and most were resistant to
ampicillin. The dominant drug-resistance pat-
terns among O139 strains isolated in Calcutta
from 1993 to 1998 were A C Co Fz S (30%), A C Co
Fz S (48.1%), A Co Fz S (49.1%), A Fz N S (96%),
A Fz N S (32%), and A Fz (98.3%).
PCR studies with 106 representative O139
strains showed that all but one strain (CO853)142 Emerging Infectious Diseases Vol. 6, No. 2, March–April 2000
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Figure 3. Antibiotic resistance pattern of the
V. cholerae O139 strains. Abbreviations: A, ampicillin;
C, chloramphenicol; Cf, ciprofloxacin; Co,
cotrimoxazole; Fz, furazolidone; G, gentamycin; N,
neomycin; Na, nalidixic acid; Nx, norfloxacin; S,
streptomycin; T, tetracycline.
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were positive for the 471-bp tcpA (El Tor)
amplicon, indicating that almost all have the
organelle required for intestinal colonization.
The presence of 301-bp ctxA, 843-bp zot, and 282-
bp  ace amplicons in all strains except CO853
indicates that all the tcpA-positive strains have
an intact CTX prophage.
The PFGE profile of three randomly selected
O139 strains, sharing the unique CTXImmCalcutta
prophage and isolated from Calcutta during 1996
and 1997, has a banding pattern similar to that of
the reference strain MO45 (ATCC 51394) isolated
during 1992 in Madras (Figure 4A). The band
patterns exhibited by all the O139 strains
differed from that of the classical and El Tor
biotype representative strains of V. cholerae O1,
569B, 2164-88, and CO840. However, the pattern
of the reference O139 strain MO45 was identical
to that of the O1 strain MO1, which was described
as the progenitor strain of the O139 serogroup (21).
The Southern blot of the PFGE DNA fragments
with O139-specific probe showed that the probe
hybridized at the same position in all the O139
strains. However, the control O1 strains and the
progenitor strain MO1 did not hybridize with the
probe (Figure 4B).
RFLP was then conducted to determine any
differences in number, location, and arrangement
of the CTX prophage in the genome of O139
strains. As the CTX prophage of the 1992-93 and
1996 O139 strains is well characterized
(8,11,16,22), we took only one representative
strain from 1992 (SG24) and 1996 (AM258)
(8,11,22). Five O139 strains (PG265, PG269,
PG316, PG337, and PG351) isolated during
September 1998 (when an upsurge in O139
strains was observed) were included in the study.
RFLP of the CTX prophage with HindIII showed
one band with SG24, PG265, PG269, PG316, and
PG351; AM258 and PG337 had three bands of 14,
9.2, and 7.0 kb (Table 3). As HindIII has no site in
the CTX prophage (23), four of the five 1998 O139
strains (PG265, PG269, PG316, and PG351), like
the 1992 O139 strain (SG24), have the CTX
prophage at only one site in the chromosome.
RFLP with PstI and BglII showed only one band
each of 5.6 kb and 8 kb, respectively, in four of the
1998 O139 strains (PG265, PG269, PG316, and
PG351), while the 1992 O139 strain (SG24)
exhibited two bands of sizes 7.0 and 5.6 and 8.0
and 7.0 kb, respectively (Table 3). As PstI and
BglII have only a single site in the CTX prophage
but not within the ctxA gene, these results
indicate that most of the 1998 O139 strains have
only one CTX prophage, unlike the 1992 O139
strain, which has two CTX prophages arranged in
tandem (Figure 5). Further, as both the 8- and
5.6-kb bands are shared by the 1992 and 1998
V. cholerae O139 strains, the downstream regions
of the CTX prophage in the 1992 and 1998
V. cholerae O139 strains are 97% similar,
Table 2. Isolation rates of Vibrio cholerae O139 from patients with acute secretory diarrhea admitted to the Infectious
Diseases Hospital, Calcutta, 1992–1998
 No. of No. (%) of samples positive for V. cholerae
samples   Total
Year screened   positive      O1    O139   Non-O1
1992   359 131  (36.5) 102  (28.4)  10    (2.8)  19  (5.3)
1993   890 491  (55.2)  24    (2.7) 443  (49.8)  24  (2.7)
1994   748 400  (53.5) 296  (39.7)  67    (8.9)  37  (4.9)
1995   873 399  (45.7) 305  (34.9)  62    (7.1)  32  (3.7)
1996 1746 399  (22.9) 234  (13.4)  62    (3.6) 103  (5.9)
1997 1643 397  (24.2) 114   (6.9) 196  (11.9)  87  (5.3)
1998 2118 642  (30.3) 416  (19.7)  73    (3.4) 153  (7.2)143 Vol. 6, No. 2, March–April 2000 Emerging Infectious Diseases
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Figure 4. Pulsed-field gel electrophoresis profiles of the V. cholerae O139 strains (A) and Southern blot of the
same gel with O139-specific probe. (B). The numbers at the top indicate the strain numbers. Lanes 1, MWM
(bacteriophage λ  ladder); 2, 569B (O1 classical Inaba); 3, 2164-88 (O1 El Tor Ogawa); 4, CO870 (O1 El Tor Ogawa);
5, MO1 (progenitor of the O139 strain); 6, MO45 (O139 strain isolated during 1992-93); 7, AM231 (O139 strain
isolated during 1996-97); 8, AM233 (O139 strain isolated during 1996-97); 9, AS258 (O139 strain isolated during
1996-97); 10, MWM (bacteriophage λ  ladder).
A B
Table 3. Fragment sizes of restriction enzyme-digested
genomic DNA of Vibrio cholerae O139 strains, isolated by
ctxA probe, Calcutta, 1992-1998
      Fragment (kb) hybridized
 Yr. iso-   Anti-          with the probe
Strain lated biogram HindIII BglII PstI
SG24 1992 CoFzS 23   8.0, 9.3,
  7.0 5.6
AM258 1996 ACCfFzNS 14.0, 23.0 7.0,
  9.2, 5.6
  7.0
PG265 1998 AFz 18.0   8.0 5.6
PG269 1998 AFz 18.0   8.0 5.6
PG316 1998 AFz 18.0   8.0 5.6
PG337 1998 AFzNS 14.0, 23 7.0,
  9.2, 5.6
  7.0
PG351 1998 AFz 16.0   8.0 5.6
suggesting that they may share the identical
location in the V. cholerae genome. Southern blot
of  HindIII-digested genomic DNA, using a ctxA
probe of the 1996 O139 strain (AM258), showed
three bands, and the Southern blots of the PstI-
and  BglII-digested genomic DNA, also using the
ctxA  probe, showed only two bands. As discussed
(8,16), the strain has the same organization of the
CTX prophage as the 1996-97 O139 strains
isolated from Calcutta. It has three tandemly
duplicated CTX prophages, with the second and
third CTX prophages being new and differing
from the first in having an altered restriction
endonuclease site (8,9) (Figure 5). The Southern
blots of the 1998 O139 strain PG337 exactly
match those of the 1996-97 representative strain
AM258 (Table 3), indicating that its structure
resembles that of the 1996-O139 strains.144 Emerging Infectious Diseases Vol. 6, No. 2, March–April 2000
Research
Figure 5. Schematic diagram of CTX prophage (not to
scale) as deduced from Southern blot hybridization
data. Arrows and boxes correspond to the restriction
sites and core regions of CTX prophage, respectively,
with hatched portions in the box representing ctxAB
genes. Restriction site abbreviations: A, AvaI; BI, BglI;
B,  BglII; H, HindIII; P, PstI.
Southern blot analysis of HindIII-digested
genomic DNA of the 15 O139 strains isolated from
different parts of India in 1998 showed four
variations when probed with ctxA. Of the 15
strains examined, eight (designated group I
strains) showed three bands of size 14, 9.2, and
7.0 kb (the pattern displayed by the 1996-97 O139
strains); two strains had three fragments of sizes
14, 12, and 7.0 kb (designated group II strains);
and four had two fragments of sizes 23 and 7.0 kb
(designated group III strains); only one had two
bands of 14 and 7.0 kb (designated group IV
strains) (Table 4). All group I and group II strains
showed a single band of about 23 kb in the blot
when digested with BglII and probed with ctxA
(Table 4), indicating that in these strains the
BglII site resides outside the CTX prophage, as
described (8). Thus, group I and group II strains
have the same unique organization of the CTX
prophage as that of the 1996-97 O139 strains (8).
The group III and group IV strains also showed a
single band when digested with BglII and probed
with  ctxA, indicating that in these strains the
BglII site may also be outside the CTX prophage
(Table 4). Representative strains of the four types
showed a common band of approximately 7 kb
when digested with BglI,  AvaI, and PstI and
probed with the ctxA probe (Table 4). Since all
these enzymes have a single restriction site in the
CTX prophage but not within the ctxA gene (23)
and the size of an intact CTX prophage is
approximately 7 kb, the 7-kb band in all these
enzymes indicates a tandem duplication in all
strains. All the group I strains have three CTX
prophages in tandem (8,16), with the second and
third prophages having a HindIII site instead of
the  BglII site in the RS region of the CTX
prophage, like the 1996-97 O139 strains
(Figure 5). The group II strains differ from the
group I strains by the position of the second band
in the blots (Table 4). Thus, the group II strains
have exactly the same arrangement of the CTX
prophage in their genome as the group I strains;
the difference in the size of the second band could
be due to the integration of the prophage at a
different site in the genome (Figure 5).
The group III and group IV strains showed
two bands in HindIII,  BglI, and AvaI blots when
probed with ctxA. There is no HindIII restriction
site in the CTX prophage of El Tor and classical
strains (23), while AvaI,  BglII and BglI have only
one site within the CTX prophage (23). In the
CTXImmCalcutta prophage, present in the 1996-97
O139 strains, the positions of the HindIII and the
BglII enzymes have been interchanged (8,9). The
presence of two bands in the blots with a common
7.0 kb in HindIII, AvaI, and BglI blots with ctxA
and one band in the BglII blot (Table 4) with same
probe indicates that group III and group IV have
two copies of the CTX prophage in tandem, with
both the CTX prophages in these strains being
the new type of the O139 CTX prophage,
CTXImmCalcutta prophage (Figure 5). Thus, these
O139 strains (all isolated in southern India) may
derive from the 1996-97 O139 strains but lack the145 Vol. 6, No. 2, March–April 2000 Emerging Infectious Diseases
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Table 4. Restriction enzyme-digested fragments of genomic DNA of Vibrio cholerae O139 strains isolated with the ctxA
probe, India, 1998
  Place (Region) Fragment size (kb) using  ctxA probe
Strain  no.     of isolation Anti-biogram  HindIII BglII BglI AvaI PstI
NPO600 Nagpur (Central) ACFzNaS 14, 12,7 23 23, 7 14, 7 9.5, 7
NPO701 Nagpur (Central) ACNaS 14, 9.2, 7 23 12, 7 23, 7 7, 5
NPO702 Nagpur (Central) AFzNaS 14, 12, 7 23 23, 7 14, 7 9.5, 7
NPO706 Nagpur (Central) ACFzNaS 14, 9.2, 7 23 12, 7 23, 7 7, 5
NPO708 Nagpur (Central) AFzNaS 14, 9.2, 7 23 12, 7 23, 7 7, 5
NPO709 Nagpur (Central) AFzNaS 14, 9.2, 7 23 12, 7 23, 7 7,5
MUO7 Murshidabad (Eastern) CFzS 14, 9.2, 7 23 12, 7 N.D. N.D.
LHO359 Ludhiana (Northern) AFzNaS 14, 9.2, 7 23 12, 7 N.D. N.D.
LHO469 Ludhiana (Northern) AFzNS 14, 9.2, 7 23 12, 7 N.D. N.D.
LHO477 Ludhiana (Northern) FzNaS 14, 9.2, 7 23 12, 7 N.D. N.D.
ALO53 Alleppey (Southern) FzS 23, 7 23 23, 7 23, 7 N.D.
ALO58 Alleppey (Southern) ACFz 23, 7 23 23, 7 23, 7 N.D.
ALO59 Alleppey (Southern) AFzNaS 23, 7 23 23, 7 23, 7 N.D.
ALO62 Alleppey (Southern) FzS 23, 7 23 23, 7 23, 7 N.D.
ALO64 Alleppey (Southern) ACFzS 14, 7 23 23, 7 23, 7 N.D.
El Tor CTX prophage of the three CTX prophages
that they have in tandem. Alternatively, these
group III and group IV strains may be a new type
of O139 that lacks the El Tor CTX prophage. The
only difference between the group III and group
IV strains is in the HindIII blot, which may be
due to polymorphism in the HindIII site (Table 4;
Figure 5).
Discussion
The emergence of V. cholerae O139 is a
puzzling event in the history of cholera. The
sudden appearance of the O139 serogroup in late
1992, its rapid spread through Southeast Asia in
1993 followed by a quiescent period during 1994-
95 and its subsequent emergence in 1996 and
1997 are inadequately understood, but character-
ize the unpredictable nature of the epidemiology
of cholera. However, the reemergence of O139 in
1996 indicates that its appearance was not a one-
time event and the serogroup has the potential to
persist and spread to other continents.
Comparison of the O139 strains isolated
during the 7-year study period revealed
interesting patterns of antibiotic resistance to
various common antibiotics. While the strains
remained largely susceptible to ciprofloxacin,
tetracycline, and gentamycin, resistance to
ampicillin and susceptibility to cotrimoxazole
(sulphamethoxazole, trimethoprim), chloram-
phenicol, and streptomycin increased during the
period of the study. Resistance to cotrimoxazole
(sulphamethoxazole and trimethoprim) and
streptomycin is encoded by a 62-kb self-
transmissible chromosomally integrated
transposon termed the SXT element, which is not
apparently linked to genes encoding O139
antigen (24). The SXT element was present in
1992-93 O139 strains and is probably silent or
absent in 1998 O139 strains, which were sensitive
to cotrimoxazole and streptomycin. The presence
of this novel region in 1996 O139 strains is
difficult to predict because these strains are
susceptible to cotrimoxazole (sulphamethoxazole
and trimethoprim) but resistant to streptomycin.
However, this pattern of rapid shift is consistent
with recent reports indicating an enhanced
mobility in genetic elements, which confers
resistance to antibiotics (25) and has also been
observed in V. cholerae O1 strains (7). A multiple-
antibiotic resistance plasmid belonging to
incompatibility group C has been associated with
drug-resistance plasmid of V. cholerae O139 (17).
Since the multidrug-resistance plasmid is self-
transmissible by conjugation, the incidence of
plasmid-carrying strains and hence drug resis-
tance may change, depending on the presence of
these plasmids in O139 strains.
Molecular studies show continuous change in
the structure and organization of CTX prophage
during the study period, along with evolution of a
new type of CTX prophage. The 1992-93 strains
have two CTX prophages connected by an RS1
element, while the 1996 O139 strains have three
CTX prophages arranged in tandem (8,22). Most
of the 1998 O139 strains from Calcutta have only
one CTX prophage, while those isolated from
other parts of India have either the arrangement146 Emerging Infectious Diseases Vol. 6, No. 2, March–April 2000
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of the 1996-97 O139 strains (group I and II
strains) or have two CTX prophages arranged in
tandem (group III and IV strains). However, as
reported elsewhere (9), the 1996 O139 strains
have two types of CTX prophages, with the first of
the three an El Tor type CTX prophage and the
second and third CTX prophages being a new type
of CTX prophage that differs primarily in the rstR
gene, the gene that codes for the repressor protein
of CTX . In 1998, we observed two new clones of
O139 at two epicenters, Calcutta and Alleppey.
From the restriction profile data of the 1998 O139
strains, it can be predicted that most of the O139
strains from Calcutta have only the El Tor type
CTX prophage and not the unique O139 CTX
prophage of the 1996 O139 strains, while the
reverse is the case with the south Indian
(Alleppey) strains. Therefore, two different
clones of O139 are circulating at two locations
with different types of CTX prophages, indicating
that reassortment in the genome is taking place
in the O139 strains. Our study indicates a
continuous emergence of new clones of toxigenic
V. cholerae, possibly through natural selection
involving unidentified factors and immunity of
the host population (25-28). Another possibility is
that the genetic reassortments observed here are
random changes in the organism. The strains
that gained advantage as a result of this
rearrangement may have infected humans and
become enriched inside the gastrointestinal tract
so that they became detectable as new toxigenic
strains. Molecular analysis of V. cholerae strains
isolated during epidemics from 1961 to 1996 in
Bangladesh revealed similar clonal diversity
among strains isolated during different epidemics
(25-29). These studies demonstrated three differ-
ent ribotypes among the V. cholerae O139 isolated
from Bangladesh, with different ribotypes often
showing different CTX prophage genotypes (26,28).
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